Brachytherapy for High-Risk Patients

ScienceDaily (Jan. 25, 2012) — Brachytherapy for high-risk prostate cancers patients has historically been considered a less effective modality, but a new study from radiation oncologists at the Kimmel Cancer Center at Jefferson suggests otherwise. Read more.

Diagnosis on a Microchip

Toronto’s medical community is buzzing about an invention that could change the way health professionals screen for infectious disease and cancer. “We’ve been working on this, really, for about a decade,” said Dr. Shana Kelley, a scientist at the University of Toronto. Kelley spoke as she held a small black device her hand, shaped like a smartphone but bulkier, with a microchip inside that Kelley says can determine in 15 minutes if you have cancer or an infectious disease. Read more.

Scroll to Top